Kurse werden geladen...
Prognose
Kaufen | 1 |
Halten | 0 |
Verkaufen | 0 |
Scoring-Modelle
Dividenden-Strategie | 0 / 15 |
HGI-Strategie | 3 / 18 |
Levermann-Strategie | -7 / 13 |
News
IM Cannabis Corp. (IMCC) Q1 2025 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:IMCC ) Q1 2025 Earnings Call May 15, 2025 9:00 AM ET Company Participants Anna Taranko - Director, Investor and Public Relations Oren Shuster - Chief Executive Officer Uri Birenberg - Chief Financial Officer Operator Good morning, and welcome to IM Cannabis' First Quarter 2025 Earnings Conference Call. Today's conference call is being recorded.» Mehr auf seekingalpha.com
IM Cannabis Reports First Quarter Financial Results
IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational Progress TORONTO and GLIL YAM, Israel , May 15, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the first quarter ended March 31, 2025. All amounts are reported in Canadian dollars and compared to the quarter ended March 31, 2024, unless otherwise stated.» Mehr auf prnewswire.com
IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction
TORONTO and GLIL YAM, Israel , May 7, 2025 /PRNewswire/ -- IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further its news release dated April 11, 2025 (the " April 11 Release"), it has filed a management information circular (the "Circular") in connection with the upcoming annual general and special meeting of the shareholders of the Company ("Shareholders") to be held on May 23, 2025 (the "Meeting"). Capitalized terms not otherwise defined herein have the meanings attributed to them in the April 11 Release.» Mehr auf prnewswire.com
Unternehmenszahlen
(EUR) | Dez. 2024 | |
---|---|---|
Umsatz | 8,93 Mio | 22,26% |
Bruttoeinkommen | 1,79 Mio | 212,57% |
Nettoeinkommen | −677,03k | 69,85% |
EBITDA | −715,20k | 46,77% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 4,54 Mio€ |
Anzahl Aktien | 3,09 Mio |
52 Wochen-Hoch/Tief | 4,26€ - 1,14€ |
Dividenden | Nein |
Beta | 1,91 |
KGV (PE Ratio) | −0,66 |
KGWV (PEG Ratio) | 0,08 |
KBV (PB Ratio) | 1,34 |
KUV (PS Ratio) | 0,13 |
Unternehmensprofil
IM Cannabis Corp. beschäftigt sich mit der Zucht, dem Anbau und der Lieferung von medizinischen Cannabisprodukten in Israel, Deutschland und Kanada. Das Unternehmen bietet Cannabisblüten und stammspezifische Cannabisextrakte unter der Marke IMC sowie Trockenblüten, Pre-Rolls und gepresstes Haschisch unter den Marken WAGNERS und Highland Grow an. Das Unternehmen beliefert medizinische Patienten und Freizeitkonsumenten. Die IM Cannabis Corp. hat ihren Hauptsitz in Tel Aviv-Yafo, Israel.
Name | IM Cannabis |
CEO | Oren Shuster |
Sitz | Tel Aviv, Israel |
Website | |
Industrie | Körperpflegeprodukte |
Börsengang | |
Mitarbeiter | 95 |
Ticker Symbole
Börse | Symbol |
---|---|
NASDAQ | IMCC |
Assets entdecken
Shareholder von IM Cannabis investieren auch in folgende Assets